TCL Archive Garb Points Out Cancer Program Is Saving ore Lives a Year Than Polio Vaccine April 6, 1979
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive Interview: Von Eschenbach Says His Goal Is to Speed Development of Interventions March 29, 2002